These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 22890921)
1. Hematopoietic stem cell mobilization with agents other than G-CSF. Hoggatt J; Pelus LM Methods Mol Biol; 2012; 904():49-67. PubMed ID: 22890921 [TBL] [Abstract][Full Text] [Related]
2. In and out of the niche: perspectives in mobilization of hematopoietic stem cells. Mohty M; Ho AD Exp Hematol; 2011 Jul; 39(7):723-9. PubMed ID: 21624427 [TBL] [Abstract][Full Text] [Related]
3. Advances in mobilization for the optimization of autologous stem cell transplantation. Vose JM; Ho AD; Coiffier B; Corradini P; Khouri I; Sureda A; Van Besien K; Dipersio J Leuk Lymphoma; 2009 Sep; 50(9):1412-21. PubMed ID: 19603345 [TBL] [Abstract][Full Text] [Related]
4. Impact of mobilization and remobilization strategies on achieving sufficient stem cell yields for autologous transplantation. Pusic I; Jiang SY; Landua S; Uy GL; Rettig MP; Cashen AF; Westervelt P; Vij R; Abboud CN; Stockerl-Goldstein KE; Sempek DS; Smith AL; DiPersio JF Biol Blood Marrow Transplant; 2008 Sep; 14(9):1045-1056. PubMed ID: 18721768 [TBL] [Abstract][Full Text] [Related]
5. Cytokine-induced hematopoietic stem and progenitor cell mobilization: unraveling interactions between stem cells and their niche. de Kruijf EFM; Fibbe WE; van Pel M Ann N Y Acad Sci; 2020 Apr; 1466(1):24-38. PubMed ID: 31006885 [TBL] [Abstract][Full Text] [Related]
6. Mobilizing stem cells from normal donors: is it possible to improve upon G-CSF? Cashen AF; Lazarus HM; Devine SM Bone Marrow Transplant; 2007 May; 39(10):577-88. PubMed ID: 17369869 [TBL] [Abstract][Full Text] [Related]
7. Plerixafor plus granulocyte colony-stimulating factor versus placebo plus granulocyte colony-stimulating factor for mobilization of CD34(+) hematopoietic stem cells in patients with multiple myeloma and low peripheral blood CD34(+) cell count: results of a subset analysis of a randomized trial. Nademanee AP; DiPersio JF; Maziarz RT; Stadtmauer EA; Micallef IN; Stiff PJ; Hsu FJ; Bridger G; Bolwell BJ Biol Blood Marrow Transplant; 2012 Oct; 18(10):1564-72. PubMed ID: 22683613 [TBL] [Abstract][Full Text] [Related]
8. Effective mobilization of hematopoietic progenitor cells in G-CSF mobilization defective CD26-/- mice through AMD3100-induced disruption of the CXCL12-CXCR4 axis. Paganessi LA; Walker AL; Tan LL; Holmes I; Rich E; Fung HC; Christopherson KW Exp Hematol; 2011 Mar; 39(3):384-90. PubMed ID: 21168468 [TBL] [Abstract][Full Text] [Related]
9. Plerixafor on demand in ten healthy family donors as a rescue strategy to achieve an adequate graft for stem cell transplantation. Gattillo S; Marktel S; Rizzo L; Malato S; Malabarba L; Coppola M; Assanelli A; Milani R; De Freitas T; Corti C; Bellio L; Ciceri F Transfusion; 2015 Aug; 55(8):1993-2000. PubMed ID: 25721167 [TBL] [Abstract][Full Text] [Related]
10. Mobilization of hematopoietic progenitors from normal donors using the combination of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor results in fewer plasmacytoid dendritic cells in the graft and enhanced donor T cell engraftment with Th1 polarization: results from a randomized clinical trial. Lonial S; Akhtari M; Kaufman J; Torre C; Lechowicz MJ; Flowers C; Sinha R; Khoury HJ; Langston AA; Waller EK Biol Blood Marrow Transplant; 2013 Mar; 19(3):460-7. PubMed ID: 23201472 [TBL] [Abstract][Full Text] [Related]
11. Flt3 ligand synergizes with granulocyte-macrophage colony-stimulating factor or granulocyte colony-stimulating factor to mobilize hematopoietic progenitor cells into the peripheral blood of mice. Brasel K; McKenna HJ; Charrier K; Morrissey PJ; Williams DE; Lyman SD Blood; 1997 Nov; 90(9):3781-8. PubMed ID: 9345066 [TBL] [Abstract][Full Text] [Related]
12. Analysis of the Complement Cascade Activation During Mobilization of Hematopoietic Stem/Progenitor Cells. Grabowska AI; Hawryluk JM Methods Mol Biol; 2019; 2017():165-175. PubMed ID: 31197776 [TBL] [Abstract][Full Text] [Related]
16. Randomized cross-over trial of progenitor-cell mobilization: high-dose cyclophosphamide plus granulocyte colony-stimulating factor (G-CSF) versus granulocyte-macrophage colony-stimulating factor plus G-CSF. Koç ON; Gerson SL; Cooper BW; Laughlin M; Meyerson H; Kutteh L; Fox RM; Szekely EM; Tainer N; Lazarus HM J Clin Oncol; 2000 May; 18(9):1824-30. PubMed ID: 10784622 [TBL] [Abstract][Full Text] [Related]
17. Plerixafor: A chemokine receptor-4 antagonist for mobilization of hematopoietic stem cells for transplantation after high-dose chemotherapy for non-Hodgkin's lymphoma or multiple myeloma. Steinberg M; Silva M Clin Ther; 2010 May; 32(5):821-43. PubMed ID: 20685493 [TBL] [Abstract][Full Text] [Related]